Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ligand Pharm (LGND)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ligand Pharm 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 USA

P: 858-550-7500

Description:

Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.

Key Statistics

Overview:

Market Capitalization, $K 2,112,109
Shares Outstanding, K 19,664
Annual Sales, $ 251,450 K
Annual Net Income, $ 143,320 K
Last Quarter Sales, $ 43,480 K
Last Quarter Net Income, $ 666,340 K
60-Month Beta 1.40
% of Insider Shareholders 7.80%
Float, K 18,130
% Float 92.20%

Growth:

1-Year Return -44.08%
3-Year Return -4.43%
5-Year Return 62.08%
5-Year Revenue Growth 413.48%
5-Year Earnings Growth 896.83%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.16 on 05/02/19
Next Earnings Date 08/05/19
Earnings Per Share ttm 6.14
EPS Growth vs. Prev Qtr -32.17%
EPS Growth vs. Prev Year -29.71%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 2.500 on 04/03/07
Dividend Payout Ratio 0.00
Most Recent Split 1-6 on 11/19/10

LGND Ratios

Ratio
Price/Earnings ttm 18.53
Price/Earnings forward 45.39
Price/Earnings to Growth 2.43
Return-on-Equity (After Tax) 19.21
Return-on-Assets (Before Tax) 7.96
Profit Margin % 57.00
Net Margin % -3.92
Debt/Equity 1.09
Price/Sales 8.90
Price/Cash Flow 12.14
Price/Book 2.07
Book Value/Share 54.93
Interest Coverage 4.59
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar